Increased spontaneous activity of a network of hippocampal neurons in culture caused by suppression of inhibitory potentials mediated by anti-gad antibodies

Autoimmunity

Volumn 41, Issue 1, 2008, Pages 66-73

  Vianello, Marika ^a   Bisson, Giacomo ^b   Maschio, Marco Dal ^b   Vassanelli, Stefano ^b   Girardi, Stefano ^b   Mucignat, Carla ^b   Fountzoulas, Kostantinos ^b   Giometto, Bruno ^a  

^a 'Ca' Foncello' Hospital   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

Diabetes; Epilepsy; GAD antibodies; Hippocampal neurons; Patch clamp

Indexed keywords

4 AMINOBUTYRIC ACID; ANTICONVULSIVE AGENT; CORTICOSTEROID; GLUTAMATE DECARBOXYLASE ANTIBODY; IMMUNOGLOBULIN;

ADULT; ANIMAL TISSUE; ANTIBODY DETECTION; ARTICLE; ATAXIA; AUTOIMMUNITY; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; DISEASE MARKER; DRUG RESISTANCE; EPILEPSY; EPILEPTOGENESIS; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; INHIBITORY POSTSYNAPTIC POTENTIAL; MALE; NERVE CELL INHIBITION; NERVE CELL MEMBRANE POTENTIAL; NERVOUS SYSTEM ELECTROPHYSIOLOGY; NEUROTRANSMISSION; NONHUMAN; PATCH CLAMP; PLASMAPHERESIS; RADIOIMMUNOASSAY; SEROLOGY; SYNAPTIC TRANSMISSION; TEMPORAL LOBE EPILEPSY;

ADULT; ANIMALS; AUTOANTIBODIES; CELLS, CULTURED; DIABETES MELLITUS; EPILEPSY; GLUTAMATE DECARBOXYLASE; HIPPOCAMPUS; HUMANS; INHIBITORY POSTSYNAPTIC POTENTIALS; MALE; NEURONS; PATCH-CLAMP TECHNIQUES; RATS; RATS, WISTAR;

EID: 38048998588     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.1080/08916930701619565     Document Type: Article

References (33)

1. Lenmark, A. (1996) Glutamic acid decarboxylase-gene to antigen to disease. J Intern Med, 240, pp. 259-277.
2. Hagopian, WA, Karlsen, AE, Gottsater, A., Landin-Olsson, M., Grubin, CE, Sundkvist, G., Petersen, JS, Boel, E., Dyrberg, T. and Lernmark, A. (1993) Quantitative assay using recombinant human islet glutamic acid decarboxylase (GAD 65) shows that 64K autoantibody positivity at onset predicts diabetes type. J Clin Invest, 91, p. 368.
3. De Aizpurua, HJ, Wilson, YM and Harrison, LC (1992) Glutamic acid decarboxylase antibodies in preclinical insulin-dependent diabetes. Proc Natl Acad Sci USA, 89, pp. 9841-9845.
4. Luhder, F., Schlosser, M., Mauch, L., Haubruck, H., Rjasanowski, I., Michaelis, D., Kohnert, KD and Ziegler, M. (1994) Autoantibodies against GAD65 rather than GAD67 precede the onset of type 1 diabetes. Autoimmunity, 19, pp. 71-80.
5. Solimena, M., Folli, F., Denis-Donini, S., Comi, GC, Pozza, G., De Camilli, P. and Vicari, AM (1988) Autoantibodies to glutamic acid decarboxylase in a patient with stiff-man syndrome, epilepsy, and Type I diabetes mellitus. N Engl J Med, 318, pp. 1012-1020.
6. Vaconcelos, OM and Dalakas, MC (2003) Stiff-person syndrome. Curr Tret Options Neurol, 5, pp. 79-90.
7. Giometto, B., Miotto, D., Faresin, F., Argentiero, V., Scaravilli, T. and Tavolato, B. (1996) Anti-gabaergic neuron autoantibodies in a patient with stiff-man syndrome and ataxia. J Neurol Sci, 143, pp. 57-59.
8. Honnorat, J., Trouillas, P., Thivolet, C., Aguera, M. and Belin, MF (1995) Autoantibodies to glutamate decarboxylase in a patient with cerebellar cortical atrophy, peripheral neuropathy, and slow eye movements. Arch Neurol, 52, pp. 462-468.
9. Casamitjana, R., Zarranz, JJ, Tolosa, E. and Graus, F. (1997) Autoantibodies to glutamic acid decarboxylase in three patients with cerebellar ataxia, late-onset insulin-dependent diabetes mellitus, and polyendocrine autoimmunity. Neurology, 49, pp. 1026-1030.
10. Honnorat, J., Saiz, A., Giometto, B., Vincent, A., Brieva, L. and de Andres, C. (2001) Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: Clinical and immunological study of 14 patients. Arch Neurol, 58, pp. 225-230.
11. Giometto, B., Nicolao, P., Macucci, M., Tavolato, B., Foxon, R. and Bottazzo, GF (1998) Temporal-lobe epilepsy associated with glutamic-acid-decarboxylase autoantibodies. Lancet, 352, p. 457.
12. Peltola, J., Kulmala, P., Isojãrvi, J., Saiz, A., Latvala, K. and Palmio, J. (2000) Autoantibodies to glutamic acid decarboxylase in patients with therapy-resistant epilepsy. Neurology, 55, pp. 46-56.
13. Nemni, R., Braghi, S., Natali-Sora, MG, Lampasona, V., Bonifacio, E., Comi, G. and Canal, N. (1994) Autoantibodies to glutamic acid decarboxylase in palatal myoclonus and epilepsy. Ann Neurol, 36, pp. 665-667.
14. Vianello, M., Morello, F., Scaravilli, T., Tavolato, B. and Giometto, B. (2003) Tremour of the mouth floor and anti-glutamic acid decarboxylase autoantibodies. Eur J Neurol, 10, pp. 513-514.
15. Giometto, B., Scaravilli, T., Nicolao, P., An, SF, Groves, M., Tavolato, B., Beckett, AA and Scaravilli, F. (1996) Detection of paraneoplastic anti-neuronal autoantibodies on paraffin-embedded tissues. Acta Neuropathol, 92, pp. 435-440.
16. Schmidli, RS, Colman, PG, Bonifacio, E., Bottazzo, GF and Harrison, LC (1994) High level of concordance between assays for glutamic acid decarboxylase antibodies. The first international glutamic acid decarboxylase antibody workshop. Diabetes, 43, pp. 1005-1009.
17. Vianello, M., Keir, G., Giometto, B., Betterle, C., Tavolato, B. and Thompson, EJ (2005) Antigenic differences between neurological and diabetic patients with anti-glutamic acid decarboxylase autoantibodies. Eur J Neurol, 12, pp. 294-299.
18. Dinkel, K., Meinck, H-M, Jury, KM, Karges, W. and Richter, W. (1998) Inhibition of γ-aminobutyric acid synthesis by glutamic acid decarboxylase autoantibodies in stiff-man syndrome. Ann Neurol, 44, pp. 194-201.
19. Ishida, K., Mitoma, H., Song, SY, Uchihara, T., Inaba, A., Eguchi, S., Kobayashi, T. and Mizusawa, H. (1999) Selective suppression of cerebellar GABAergic transmission by an autoantibody to glutamic acid decarboxylase. Ann Neurol, 46, pp. 263-267.
20. Mitoma, H., Song, SY, Ishida, K., Yamakuni, T., Kobayashi, T. and Mizusawa, H. (2000) Presynaptic impairment of cerebellar inhibitory synapses by an autoantibody to glutamate decarboxylase. J Neurol Sci, 175, pp. 40-44.
21. Takenoshita, H., Shizuka-Ikeda, M., Mitoma, H., Song, S., Harigaya, Y. and Igeta, Y. (2001) Presynaptic inhibition of cerebellar GABAergic transmission by glutamate decarboxylase autoantibodies in progressive cerebellar ataxia. JNNP, 70, pp. 386-389.
22. Vianello, M., Giometto, B., Vassanelli, S., Canato, M., Betterle, C. and Mucignat, C. (2006) Peculiar labelling of cultured hippocampal neurons by different sera harbouring anti-glutamic acid decarboxylase autoantibodies (GAD-Ab). Exp Neurol, 202, pp. 514-518.
23. Franaszczuk, PJ, Bergey, GK and Kudela, P. (1995) Detection of spontaneous postsynaptic potentials. Comput Biomed Res, 28:5, pp. 354-370.
24. Moré, JJ and Sorensen, DC (1983) Computing a trust region step. SIAM J Sci Stat Comput, 3, pp. 553-572.
25. Destexhe, A., Mainen, ZF and Sejnowski, TJ (1994) Synthesis of models for excitable membranes, synaptic transmission and neuromodulation using a common kinetic formalism. J Comput Neurosci, 1:3, pp. 195-230.
26. Dayan, P. and Abbott, LF (2001) Theoretical neuroscience: Computational and mathematical modelling of neural systems, MIT Press, Cambridge, MA
27. Dupuy, ST and Houser, CR (1996) Prominent expression of two forms of glutamate decarboxylase in the embryonic and early postnatal rat hippocampal formation. J Neurol Sci, 16, pp. 6919-6932.
28. Kato-Negishi, M., Muramoto, K., Kawahara, M., Kuroda, Y. and Ichikawa, M. (2004) Developmental changes of GABAergic synapses formed between primary cultured cortical neurons. Dev Brain Res, 152, pp. 99-108.
29. Alarcon-Segovia, D., Ruid-Arguelles, A. and Llorente, L. (1996) Broken dogma: Penetration of autoantibodies into living cells. Immunol Today, 17, pp. 163-164.
30. Madaio, MP, Fabbi, M. and Tiso, M. (1996) Spontaneously produced anti-DNA/DNase I autoantibodies modulate nuclear apoptosis in living cells. Eur J Immunol, 26, pp. 3035-3041.
31. Koerner, C., Wieland, B., Richter, W. and Meinck, HM (2004) Stiff-person syndromes. Motor cortex hyperexcitability correlates with anti-GAD autoimmunity. Neurology, 62, pp. 1357-1362.
32. Kash, SF, Johnson, RS, Tecott, LH, Noebels, JL, Mayfield, RD, Hanahan, D. and Baekkeskov, S. (1997) Epilepsy in mice deficient in the 65-kDa isoform of glutamic acid decarboxylase. Proc Natl Acad Sci USA, 94, pp. 14060-14065.
33. During, MJ, Symes, CW, Lawlor, PA, Lin, J., Dunning, J. and Fitzsimons, HL (2000) An oral vaccine against NMDAR1 with efficacy in experimental stroke and epilepsy. Science, 287, pp. 1453-1459.